HBV associated nephrotic syndrome: resolution with oral lamivudine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12716723.
- Also identified by PMC identifier 1719558.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 6 year old boy presenting with a five month history of fever, lethargy, and anorexia, was found to have hepatitis B associated membranous glomerulonephropathy and nephrotic syndrome. After two months treatment with oral lamivudine, his proteinuria cleared and serum albumin and aminotransferases normalised, associated with disappearance of hepatitis B e antigen (HBeAg) and appearance of anti-HBeAg antibodies. After 12 months, without side effects, lamivudine was discontinued. He remains well 11 months off treatment.
Medical subject headings
- Hepatitis B
- Lamivudine
- Nephrotic Syndrome
- Reverse Transcriptase Inhibitors